Columbia Capital — 2022 Investments
3 investments dated 2022 · listed companies and verified rows first · show all
BLUEWAVE manufactures an FDA Class II medical device for at-home disinfection of orthotic and prosthetic devices using proprietary vacuum-infusion technology, designed to reduce bacterial contamination and infection risk in patients with diabetes, limb loss, or immune deficiency.
HealthtechMedical DevicesOrange City, US
Justin Zhou(Founder)in
Co-investorsPS27 Ventures
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Washington Harbour Federal IT Holdings, LLCHigh Band Holdings
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.


